Regulation of translational effectors by amino acid and mammalian target of rapamycin signaling pathways. Possible involvement of autophagy in cultured hepatoma cells - PubMed (original) (raw)
. 1999 Jan 8;274(2):1058-65.
doi: 10.1074/jbc.274.2.1058.
Affiliations
- PMID: 9873051
- DOI: 10.1074/jbc.274.2.1058
Free article
Regulation of translational effectors by amino acid and mammalian target of rapamycin signaling pathways. Possible involvement of autophagy in cultured hepatoma cells
K Shigemitsu et al. J Biol Chem. 1999.
Free article
Abstract
Amino acid deprivation of Chinese hamster ovary cells overexpressing human insulin receptors results in deactivation of p70 S6 kinase (p70) and dephosphorylation of eukaryotic initiation factor 4E-binding protein 1 (4E-BP1), which become unresponsive to insulin; readdition of amino acids restores these responses in a rapamycin-sensitive manner, suggesting that amino acids and mammalian target of rapamycin signal through common effectors. Contrarily, withdrawal of medium amino acids from the hepatoma cell line H4IIE does not abolish the ability of insulin to stimulate p70 and 4E-BP1. The addition of 3-methyladenine (3MA) to H4IIE cells deprived of amino acids inhibited the increment in protein degradation caused by amino acid withdrawal nearly completely at 10 mM and also strongly inhibited the ability of insulin to stimulate p70 and 4E-BP1 at 10 mM. Treatment of H4IIE cells with 3MA did not alter the ability of insulin to activate tyrosine phosphorylation, phosphoinositide 3-kinase, or mitogen-activated protein kinase. In conclusion, the ability of H4IIE cells to maintain the insulin responsiveness of the mammalian target of rapamycin-dependent signaling pathways impinging on p70 and 4E-BP1 without exogenous amino acids reflects the generation of amino acids endogenously through a 3MA-sensitive process, presumably autophagy, a major mechanism of facultative protein degradation in liver.
Similar articles
- Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism.
Hara K, Yonezawa K, Weng QP, Kozlowski MT, Belham C, Avruch J. Hara K, et al. J Biol Chem. 1998 Jun 5;273(23):14484-94. doi: 10.1074/jbc.273.23.14484. J Biol Chem. 1998. PMID: 9603962 - Assessment of cell-signaling pathways in the regulation of mammalian target of rapamycin (mTOR) by amino acids in rat adipocytes.
Pham PT, Heydrick SJ, Fox HL, Kimball SR, Jefferson LS Jr, Lynch CJ. Pham PT, et al. J Cell Biochem. 2000 Sep 7;79(3):427-41. doi: 10.1002/1097-4644(20001201)79:3<427::aid-jcb80>3.0.co;2-0. J Cell Biochem. 2000. PMID: 10972980 - Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability.
Beugnet A, Tee AR, Taylor PM, Proud CG. Beugnet A, et al. Biochem J. 2003 Jun 1;372(Pt 2):555-66. doi: 10.1042/BJ20021266. Biochem J. 2003. PMID: 12611592 Free PMC article. - Interplay between insulin and nutrients in the regulation of translation factors.
Proud CG, Wang X, Patel JV, Campbell LE, Kleijn M, Li W, Browne GJ. Proud CG, et al. Biochem Soc Trans. 2001 Aug;29(Pt 4):541-7. doi: 10.1042/bst0290541. Biochem Soc Trans. 2001. PMID: 11498025 Review. - TOR action in mammalian cells and in Caenorhabditis elegans.
Long X, Müller F, Avruch J. Long X, et al. Curr Top Microbiol Immunol. 2004;279:115-38. doi: 10.1007/978-3-642-18930-2_8. Curr Top Microbiol Immunol. 2004. PMID: 14560955 Review.
Cited by
- Developing a Tanshinone IIA Memetic by Targeting MIOS to Regulate mTORC1 and Autophagy in Glioblastoma.
Shinhmar S, Schaf J, Lloyd Jones K, Pardo OE, Beesley P, Williams RSB. Shinhmar S, et al. Int J Mol Sci. 2024 Jun 14;25(12):6586. doi: 10.3390/ijms25126586. Int J Mol Sci. 2024. PMID: 38928292 Free PMC article. - Rapamycin Perfluorocarbon Nanoparticle Mitigates Cisplatin-Induced Acute Kidney Injury.
Zhou Q, Quirk JD, Hu Y, Yan H, Gaut JP, Pham CTN, Wickline SA, Pan H. Zhou Q, et al. Int J Mol Sci. 2023 Mar 23;24(7):6086. doi: 10.3390/ijms24076086. Int J Mol Sci. 2023. PMID: 37047059 Free PMC article. - A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond.
Noel MS, Kim S, Hartley ML, Wong S, Picozzi VJ, Staszewski H, Kim DW, Van Tornout JM, Philip PA, Chung V, Ocean AJ, Wang-Gillam A. Noel MS, et al. Cancer Med. 2022 Nov;11(22):4169-4181. doi: 10.1002/cam4.4768. Epub 2022 May 2. Cancer Med. 2022. PMID: 35499204 Free PMC article. Clinical Trial. - Regulation of mTORC1 by amino acids in mammalian cells: A general picture of recent advances.
Zhang S, Lin X, Hou Q, Hu Z, Wang Y, Wang Z. Zhang S, et al. Anim Nutr. 2021 Dec;7(4):1009-1023. doi: 10.1016/j.aninu.2021.05.003. Epub 2021 Sep 14. Anim Nutr. 2021. PMID: 34738031 Free PMC article. Review. - Protective Effect of Curcumin on Bone Trauma in a Rat Model via Expansion of Myeloid Derived Suppressor Cells.
Zhang F, Liu F, Yu S, Zhang G, Li J, Sun X. Zhang F, et al. Med Sci Monit. 2020 Nov 13;26:e924724. doi: 10.12659/MSM.924724. Med Sci Monit. 2020. PMID: 33184252 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials